ERBB2 and ductal breast carcinoma in situ: SRC-3 also was required to maintain myoepithelial progenitor cells in ductal carcinoma in situ (DCIS) lesion via NOTCH and HER-2/HER-3 signaling molecules, thus increasing incidence of invasive breast cancer [109].